Human Phenotype Ontology 
Grandparent Node:
expand
Abnormality of the endocrine system (HP:0000818)help
Parent Node:
expand
Abnormal circulating hormone concentration (HP:0003117)help
..Starting node
..expand
Abnormal circulating gonadotropin concentration (HP:0030338)help
Term ID: 30338
Name: Abnormal circulating gonadotropin concentration
Synonym: Abnormal circulating gonadotropin level
Definition: An anomaly of the circulating level of a gonadotropin, that is, of a protein hormone secreted by gonadotrope cells of the anterior pituitary of vertebrates. The primary gonadotropins are luteinizing hormone (LH) and follicle-stimulating hormone (FSH).
Comments:
Reference: HP:0030338
Genes and Diseases:
 
       Child Nodes:
........expandIncreased circulating gonadotropin level (HP:0000837) help
................... HP:0008232 Elevated circulating follicle stimulating hormone level
................... HP:0011969 Elevated circulating luteinizing hormone level
........expandDecreased circulating gonadotropin level (HP:0030339) help
................... HP:0030341 Decreased circulating follicle stimulating hormone level
................... HP:0030344 Decreased circulating luteinizing hormone level
........expandAbnormal circulating luteinizing hormone level (HP:0030345) help
................... HP:0011969 Elevated circulating luteinizing hormone level
................... HP:0030344 Decreased circulating luteinizing hormone level
........expandAbnormal circulating follicle-stimulating hormone level (HP:0030346) help
................... HP:0008232 Elevated circulating follicle stimulating hormone level
................... HP:0030341 Decreased circulating follicle stimulating hormone level

 Sister Nodes: 
..expandAbnormal adiponectin level (HP:0030684) help
..expandAbnormal circulating adrenocorticotropin concentration (HP:0011043) help
..expandAbnormal circulating androgen level (HP:0030347) help
..expandAbnormal circulating antimullerian hormone concentration (HP:0031101) help
..expandAbnormal circulating estrogen level (HP:0025132) help
..expandAbnormal circulating inhibin level (HP:0031099) help
..expandAbnormal circulating insulin concentration (HP:0040214) help
..expandAbnormal circulating leptin concentration (HP:0004361) help
..expandAbnormal circulating osteocalcin level (HP:0031427) help
..expandAbnormal circulating pregnenolone concentration (HP:0031187) help
..expandAbnormal circulating progesterone level (HP:0031212) help
..expandAbnormal circulating thyroid hormone concentration (HP:0031508) help
..expandAbnormal glucagon level (HP:0030687) help
..expandAbnormal gonadotropin-releasing hormone concentration (HP:0500012) help
..expandAbnormal serum insulin-like growth factor 1 level (HP:0030352) help
..expandAbnormality of circulating catecholamine level (HP:0012099) help
..expandAbnormality of circulating glucocorticoid level (HP:0012111) help
..expandDecreased circulating dehydroepiandrosterone concentration (HP:0031214) help
..expandDecreased circulating dehydroepiandrosterone-sulfate concentration (HP:0031215) help
..expandDecreased circulating parathyroid hormone level (HP:0031817) help
..expandDecreased response to growth hormone stimulation test (HP:0000824) help
..expandElevated circulating parathyroid hormone level (HP:0003165) help
..expandElevated vascular endothelial growth factor level (HP:0031052) help
..expandFasting hypoglycemia (HP:0003162) help
..expandIncreased pituitary glycoprotein hormone alpha subunit level (HP:0031208) help
..expandIncreased serum serotonin (HP:0003144) help
..expandobsolete Increased serum 1,25-dihydroxyvitamin D3 (HP:0003152) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0AKT1 CL E G H207391ORPHA:2495Meningioma54
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0ANOS1 CL E G H37306211OMIM:308700Hypogonadotropic hypogonadism 1 with or without anosmia65
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0AR CL E G H367644OMIM:300068Androgen insensitivity syndrome125
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0AR CL E G H367644ORPHA:99429Complete androgen insensitivity syndrome125
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0AR CL E G H367644ORPHA:90797Partial androgen insensitivity syndrome125
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0BAP1 CL E G H8314950ORPHA:2495Meningioma184
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0BMP15 CL E G H92101068ORPHA:24346,XX gonadal dysgenesis16
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0BMPR1B CL E G H6581077OMIM:609441Acromesomelic dysplasia, Demirhan type90
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0BNC1 CL E G H6461081ORPHA:24346,XX gonadal dysgenesis
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0BNC1 CL E G H6461081OMIM:618723PREMATURE OVARIAN FAILURE 16; POF16
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0C14ORF39 CL E G H31776119849ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutation
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0C14ORF39 CL E G H31776119849OMIM:619203PREMATURE OVARIAN FAILURE 18; POF18
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0CBX2 CL E G H847331552OMIM:61308046XY sex reversal 53
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0CCDC34 CL E G H9105725079ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutation
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0CDH23 CL E G H6407213733ORPHA:91347TSH-secreting pituitary adenoma636
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0CFTR CL E G H10801884ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutation1371
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0CNBP CL E G H755513164OMIM:602668Dystrophia myotonica 21
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0CPE CL E G H13632303OMIM:619326BDV SYNDROME; BDVS
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0CYB5A CL E G H15282570ORPHA:9079646,XY disorder of sex development due to isolated 17,20-lyase deficiency2
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0CYP11A1 CL E G H15832590ORPHA:16855846,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiency31
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0CYP11A1 CL E G H15832590ORPHA:289548Inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency31
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0CYP17A1 CL E G H15862593ORPHA:9079646,XY disorder of sex development due to isolated 17,20-lyase deficiency53
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0CYP17A1 CL E G H15862593ORPHA:90793Congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency53
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0DHH CL E G H508462865ORPHA:16856346,XY gonadal dysgenesis-motor and sensory neuropathy syndrome21
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0DHX37 CL E G H5764717210OMIM:27325046, XY sex reversal 112
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0DHX37 CL E G H5764717210ORPHA:25151046,XY partial gonadal dysgenesis2
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0DIAPH2 CL E G H17302877OMIM:300511Premature ovarian failure 2A6
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0DMRT3 CL E G H5852413909ORPHA:25151046,XY partial gonadal dysgenesis1
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0DMXL2 CL E G H233122938ORPHA:453533Polyendocrine-polyneuropathy syndrome3
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0ERCC6 CL E G H20743438OMIM:616946PREMATURE OVARIAN FAILURE 11; POF11199
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0ESR1 CL E G H20993467ORPHA:785Estrogen resistance syndrome13
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0ESR2 CL E G H21003468OMIM:618187Ovarian dysgenesis 8
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0FAM111A CL E G H6390124725ORPHA:93325Autosomal dominant Kenny-Caffey syndrome8
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0FANCM CL E G H5769723168ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutation107
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0FANCM CL E G H5769723168OMIM:618086Spermatogenic failure 28107
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0FGD1 CL E G H22453663OMIM:305400Aarskog-Scott syndrome62
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0FIGLA CL E G H34401824669OMIM:612310PREMATURE OVARIAN FAILURE 6; POF617
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0FKBP6 CL E G H84683722OMIM:620103
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0FMR1 CL E G H23323775OMIM:311360Premature ovarian failure 130
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0FOXL2 CL E G H6681092OMIM:110100Blepharophimosis, epicanthus inversus, and ptosis92
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0FOXL2 CL E G H6681092ORPHA:572333Blepharophimosis-ptosis-epicanthus inversus syndrome plus92
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0FSHB CL E G H24883964OMIM:229070Hypogonadotropic hypogonadism 24 without anosmia23
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0FSHR CL E G H24923969ORPHA:24346,XX gonadal dysgenesis50
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0FSHR CL E G H24923969OMIM:233300Ovarian dysgenesis 150
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0FSHR CL E G H24923969ORPHA:64739Ovarian hyperstimulation syndrome50
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0GATA4 CL E G H26264173ORPHA:25151046,XY partial gonadal dysgenesis87
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0GCNA CL E G H9395315805OMIM:301077SPERMATOGENIC FAILURE, X-LINKED, 4; SPGFX4
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0GDF9 CL E G H26614224OMIM:618014Premature ovarian failure 142
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0GNRH1 CL E G H27964419OMIM:614841Hypogonadotropic hypogonadism 12 with or without anosmia15
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0HESX1 CL E G H88204877ORPHA:226307Hypothyroidism due to deficient transcription factors involved in pituitary development or function21
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0HFM1 CL E G H16404520193OMIM:615724Premature ovarian failure 96
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0HSD17B4 CL E G H32955213OMIM:233400Perrault syndrome 198
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0KISS1 CL E G H38146341OMIM:614842Hypogonadotropic hypogonadism 13 with or without anosmia3
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0KISS1R CL E G H846344510OMIM:176400Precocious puberty, central14
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0KLHL10 CL E G H31771918829ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutation3
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0LARS2 CL E G H2339517095OMIM:615300Perrault syndrome 454
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0LGR4 CL E G H5536613299OMIM:619613DELAYED PUBERTY, SELF-LIMITED; DPSL1
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0LHB CL E G H39726584OMIM:228300Hypogonadotropic hypogonadism 23 without anosmia9
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0LHCGR CL E G H39736585OMIM:238320Hypergonadotropic hypogonadism67
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0LHX3 CL E G H80226595ORPHA:226307Hypothyroidism due to deficient transcription factors involved in pituitary development or function51
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0LHX4 CL E G H8988421734ORPHA:226307Hypothyroidism due to deficient transcription factors involved in pituitary development or function43
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0MAGEL2 CL E G H545516814ORPHA:98754Prader-Willi syndrome due to maternal uniparental disomy of chromosome 1563
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0MAGEL2 CL E G H545516814ORPHA:177901Prader-Willi syndrome due to paternal deletion of 15q11q13 type 163
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0MAGEL2 CL E G H545516814ORPHA:177904Prader-Willi syndrome due to paternal deletion of 15q11q13 type 263
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0MAP3K1 CL E G H42146848ORPHA:25151046,XY partial gonadal dysgenesis13
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0MCM8 CL E G H8451516147OMIM:612885Premature ovarian failure 104
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0MCM9 CL E G H25439421484OMIM:616185Ovarian dysgenesis 44
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0MEIOB CL E G H25452828569ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutation
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0MRPS22 CL E G H5694514508ORPHA:24346,XX gonadal dysgenesis25
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0MSH4 CL E G H44387327OMIM:619938
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0MSH5 CL E G H44397328OMIM:617442Premature ovarian failure 135
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0NANOS1 CL E G H34071923044ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutation4
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0NANOS1 CL E G H34071923044ORPHA:399808Male infertility with teratozoospermia due to single gene mutation4
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0NDN CL E G H46927675ORPHA:98754Prader-Willi syndrome due to maternal uniparental disomy of chromosome 15
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0NDN CL E G H46927675ORPHA:177901Prader-Willi syndrome due to paternal deletion of 15q11q13 type 1
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0NDN CL E G H46927675ORPHA:177904Prader-Willi syndrome due to paternal deletion of 15q11q13 type 2
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0NF2 CL E G H47717773ORPHA:2495Meningioma220
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0NHLH2 CL E G H48087818OMIM:619755HYPOGONADOTROPIC HYPOGONADISM 27 WITHOUT ANOSMIA; HH27
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0NR0B1 CL E G H1907960ORPHA:25151046,XY partial gonadal dysgenesis48
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0NR5A1 CL E G H25167983ORPHA:24346,XX gonadal dysgenesis38
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0NR5A1 CL E G H25167983ORPHA:25151046,XY partial gonadal dysgenesis38
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0NR5A1 CL E G H25167983OMIM:61296546XY sex reversal 338
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0NR5A1 CL E G H25167983ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutation38
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0NR5A1 CL E G H25167983OMIM:612964PREMATURE OVARIAN FAILURE 7; POF738
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0NSMCE2 CL E G H28605326513OMIM:617253Seckel syndrome 102
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0NUP107 CL E G H5712229914ORPHA:24346,XX gonadal dysgenesis5
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0OCA2 CL E G H49488101ORPHA:98754Prader-Willi syndrome due to maternal uniparental disomy of chromosome 15121
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0OCA2 CL E G H49488101ORPHA:177901Prader-Willi syndrome due to paternal deletion of 15q11q13 type 1121
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0OCA2 CL E G H49488101ORPHA:177904Prader-Willi syndrome due to paternal deletion of 15q11q13 type 2121
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0OTX2 CL E G H50158522OMIM:613986Pituitary hormone deficiency, combined, 641
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0PDGFB CL E G H51558800ORPHA:2495Meningioma9
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0PIK3CA CL E G H52908975ORPHA:2495Meningioma162
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0PNLDC1 CL E G H15419721185ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutation
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0PNPLA6 CL E G H1090816268OMIM:215470Boucher-Neuhauser syndrome103
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0POLA1 CL E G H54229173ORPHA:163976X-linked intellectual disability, Van Esch type2
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0POLR3H CL E G H17156830349ORPHA:24346,XX gonadal dysgenesis
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0POR CL E G H54479208ORPHA:95699Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency76
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0POU1F1 CL E G H54499210ORPHA:226307Hypothyroidism due to deficient transcription factors involved in pituitary development or function36
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0PPP2R3C CL E G H5501217485OMIM:618419Gonadal dysgenesis, dysmorphic facies, retinal dystrophy, and myopathy
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0PRDM13 CL E G H5933613998OMIM:619761CEREBELLAR DYSFUNCTION, IMPAIRED INTELLECTUAL DEVELOPMENT, AND HYPOGONADOTROPIC HYPOGONADISM; CDIDHH2
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0PROP1 CL E G H56269455ORPHA:226307Hypothyroidism due to deficient transcription factors involved in pituitary development or function54
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0PSMC3IP CL E G H2989317928ORPHA:24346,XX gonadal dysgenesis2
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0PSMC3IP CL E G H2989317928OMIM:614324Ovarian dysgenesis 32
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0SEMA3A CL E G H1037110723OMIM:614897Hypogonadotropic hypogonadism 16 with or without anosmia14
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0SHOC1 CL E G H15840126535OMIM:619949
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0SMARCB1 CL E G H659811103ORPHA:2495Meningioma87
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0SMARCE1 CL E G H660511109ORPHA:2495Meningioma47
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0SMO CL E G H660811119ORPHA:2495Meningioma22
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0SNRPN CL E G H663811164ORPHA:98754Prader-Willi syndrome due to maternal uniparental disomy of chromosome 1537
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0SNRPN CL E G H663811164ORPHA:177901Prader-Willi syndrome due to paternal deletion of 15q11q13 type 137
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0SNRPN CL E G H663811164ORPHA:177904Prader-Willi syndrome due to paternal deletion of 15q11q13 type 237
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0SOHLH1 CL E G H40238127845ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutation3
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0SOX9 CL E G H666211204ORPHA:25151046,XY partial gonadal dysgenesis109
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0SPIDR CL E G H2351428971ORPHA:24346,XX gonadal dysgenesis2
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0SPIDR CL E G H2351428971OMIM:619665OVARIAN DYSGENESIS 9; ODG92
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0SRY CL E G H673611311ORPHA:177245,X/46,XY mixed gonadal dysgenesis23
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0SRY CL E G H673611311ORPHA:25151046,XY partial gonadal dysgenesis23
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0SRY CL E G H673611311OMIM:40004546XX sex reversal 123
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0SRY CL E G H673611311OMIM:40004446XY sex reversal 123
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0STAG3 CL E G H1073411356OMIM:615723Premature ovarian failure 84
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0SUFU CL E G H5168416466ORPHA:2495Meningioma124
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0SYCE1 CL E G H9342628852ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutation4
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0SYCP3 CL E G H5051118130ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutation12
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0TAF4B CL E G H687511538ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutation1
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0TDRD9 CL E G H12240220122ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutation
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0TERT CL E G H701511730ORPHA:2495Meningioma238
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0TEX11 CL E G H5615911733ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutation5
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0TEX14 CL E G H5615511737ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutation1
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0TEX15 CL E G H5615411738ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutation1
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0TRAF7 CL E G H8423120456ORPHA:2495Meningioma
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0VAMP7 CL E G H684511486ORPHA:25151046,XY partial gonadal dysgenesis2
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0WT1 CL E G H749012796ORPHA:25151046,XY partial gonadal dysgenesis177
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0WT1 CL E G H749012796ORPHA:347Frasier syndrome177
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0WWOX CL E G H5174112799ORPHA:25151046,XY partial gonadal dysgenesis149
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0XRCC2 CL E G H751612829ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutation125
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0XRCC2 CL E G H751612829OMIM:619146PREMATURE OVARIAN FAILURE 17; POF17125
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0ZFPM2 CL E G H2341416700ORPHA:25151046,XY partial gonadal dysgenesis31
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0ZMYND15 CL E G H8422520997ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutation1
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0ZMYND15 CL E G H8422520997OMIM:615842Spermatogenic failure 141
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0ZSWIM7 CL E G H12515026993ORPHA:24346,XX gonadal dysgenesis
HP:0030338HP:0030338Abnormal circulating gonadotropin concentration0ZSWIM7 CL E G H12515026993OMIM:619834OVARIAN DYSGENESIS 10; ODG10
HP:0030338HP:0030339Decreased circulating gonadotropin concentration1AKT1 CL E G H207391ORPHA:2495Meningioma54
HP:0030338HP:0030345Abnormal circulating luteinizing hormone concentration1AKT1 CL E G H207391ORPHA:2495Meningioma54
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1AKT1 CL E G H207391ORPHA:2495Meningioma54
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1ANOS1 CL E G H37306211OMIM:308700Hypogonadotropic hypogonadism 1 with or without anosmia65
HP:0030338HP:0030345Abnormal circulating luteinizing hormone concentration1ANOS1 CL E G H37306211OMIM:308700Hypogonadotropic hypogonadism 1 with or without anosmia65
HP:0030338HP:0030339Decreased circulating gonadotropin concentration1ANOS1 CL E G H37306211OMIM:308700Hypogonadotropic hypogonadism 1 with or without anosmia65
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1AR CL E G H367644OMIM:300068Androgen insensitivity syndrome125
HP:0030338HP:0000837Increased circulating gonadotropin level1AR CL E G H367644OMIM:300068Androgen insensitivity syndrome125
HP:0030338HP:0030345Abnormal circulating luteinizing hormone concentration1AR CL E G H367644OMIM:300068Androgen insensitivity syndrome125
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1AR CL E G H367644ORPHA:99429Complete androgen insensitivity syndromeHP:0040284 - Very rare125
HP:0030338HP:0000837Increased circulating gonadotropin level1AR CL E G H367644ORPHA:99429Complete androgen insensitivity syndrome125
HP:0030338HP:0030345Abnormal circulating luteinizing hormone concentration1AR CL E G H367644ORPHA:99429Complete androgen insensitivity syndrome125
HP:0030338HP:0030345Abnormal circulating luteinizing hormone concentration1AR CL E G H367644ORPHA:90797Partial androgen insensitivity syndrome125
HP:0030338HP:0000837Increased circulating gonadotropin level1AR CL E G H367644ORPHA:90797Partial androgen insensitivity syndrome125
HP:0030338HP:0030339Decreased circulating gonadotropin concentration1BAP1 CL E G H8314950ORPHA:2495Meningioma184
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1BAP1 CL E G H8314950ORPHA:2495Meningioma184
HP:0030338HP:0030345Abnormal circulating luteinizing hormone concentration1BAP1 CL E G H8314950ORPHA:2495Meningioma184
HP:0030338HP:0000837Increased circulating gonadotropin level1BMP15 CL E G H92101068ORPHA:24346,XX gonadal dysgenesisHP:0040281 - Very frequent16
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1BMPR1B CL E G H6581077OMIM:609441Acromesomelic dysplasia, Demirhan type90
HP:0030338HP:0000837Increased circulating gonadotropin level1BMPR1B CL E G H6581077OMIM:609441Acromesomelic dysplasia, Demirhan type90
HP:0030338HP:0030345Abnormal circulating luteinizing hormone concentration1BMPR1B CL E G H6581077OMIM:609441Acromesomelic dysplasia, Demirhan type90
HP:0030338HP:0000837Increased circulating gonadotropin level1BNC1 CL E G H6461081ORPHA:24346,XX gonadal dysgenesisHP:0040281 - Very frequent
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1BNC1 CL E G H6461081OMIM:618723PREMATURE OVARIAN FAILURE 16; POF16
HP:0030338HP:0000837Increased circulating gonadotropin level1BNC1 CL E G H6461081OMIM:618723PREMATURE OVARIAN FAILURE 16; POF16
HP:0030338HP:0000837Increased circulating gonadotropin level1C14ORF39 CL E G H31776119849ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutationHP:0040281 - Very frequent
HP:0030338HP:0000837Increased circulating gonadotropin level1C14ORF39 CL E G H31776119849OMIM:619203PREMATURE OVARIAN FAILURE 18; POF18
HP:0030338HP:0030345Abnormal circulating luteinizing hormone concentration1C14ORF39 CL E G H31776119849OMIM:619203PREMATURE OVARIAN FAILURE 18; POF18
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1C14ORF39 CL E G H31776119849OMIM:619203PREMATURE OVARIAN FAILURE 18; POF18
HP:0030338HP:0000837Increased circulating gonadotropin level1CBX2 CL E G H847331552OMIM:61308046XY sex reversal 53
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1CBX2 CL E G H847331552OMIM:61308046XY sex reversal 53
HP:0030338HP:0000837Increased circulating gonadotropin level1CCDC34 CL E G H9105725079ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutationHP:0040281 - Very frequent
HP:0030338HP:0000837Increased circulating gonadotropin level1CDH23 CL E G H6407213733ORPHA:91347TSH-secreting pituitary adenomaHP:0040283 - Occasional636
HP:0030338HP:0000837Increased circulating gonadotropin level1CFTR CL E G H10801884ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutationHP:0040281 - Very frequent1371
HP:0030338HP:0000837Increased circulating gonadotropin level1CNBP CL E G H755513164OMIM:602668Dystrophia myotonica 21
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1CNBP CL E G H755513164OMIM:602668Dystrophia myotonica 21
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1CPE CL E G H13632303OMIM:619326BDV SYNDROME; BDVS
HP:0030338HP:0030339Decreased circulating gonadotropin concentration1CPE CL E G H13632303OMIM:619326BDV SYNDROME; BDVS
HP:0030338HP:0030345Abnormal circulating luteinizing hormone concentration1CYB5A CL E G H15282570ORPHA:9079646,XY disorder of sex development due to isolated 17,20-lyase deficiency2
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1CYB5A CL E G H15282570ORPHA:9079646,XY disorder of sex development due to isolated 17,20-lyase deficiency2
HP:0030338HP:0000837Increased circulating gonadotropin level1CYB5A CL E G H15282570ORPHA:9079646,XY disorder of sex development due to isolated 17,20-lyase deficiency2
HP:0030338HP:0000837Increased circulating gonadotropin level1CYP11A1 CL E G H15832590ORPHA:16855846,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiency31
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1CYP11A1 CL E G H15832590ORPHA:16855846,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiency31
HP:0030338HP:0030345Abnormal circulating luteinizing hormone concentration1CYP11A1 CL E G H15832590ORPHA:16855846,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiency31
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1CYP11A1 CL E G H15832590ORPHA:289548Inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency31
HP:0030338HP:0030345Abnormal circulating luteinizing hormone concentration1CYP11A1 CL E G H15832590ORPHA:289548Inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency31
HP:0030338HP:0000837Increased circulating gonadotropin level1CYP11A1 CL E G H15832590ORPHA:289548Inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency31
HP:0030338HP:0000837Increased circulating gonadotropin level1CYP17A1 CL E G H15862593ORPHA:9079646,XY disorder of sex development due to isolated 17,20-lyase deficiency53
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1CYP17A1 CL E G H15862593ORPHA:9079646,XY disorder of sex development due to isolated 17,20-lyase deficiency53
HP:0030338HP:0030345Abnormal circulating luteinizing hormone concentration1CYP17A1 CL E G H15862593ORPHA:9079646,XY disorder of sex development due to isolated 17,20-lyase deficiency53
HP:0030338HP:0030345Abnormal circulating luteinizing hormone concentration1CYP17A1 CL E G H15862593ORPHA:90793Congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency53
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1CYP17A1 CL E G H15862593ORPHA:90793Congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency53
HP:0030338HP:0000837Increased circulating gonadotropin level1CYP17A1 CL E G H15862593ORPHA:90793Congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiencyHP:0040281 - Very frequent53
HP:0030338HP:0000837Increased circulating gonadotropin level1DHH CL E G H508462865ORPHA:16856346,XY gonadal dysgenesis-motor and sensory neuropathy syndromeHP:0040281 - Very frequent21
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1DHX37 CL E G H5764717210OMIM:27325046, XY sex reversal 112
HP:0030338HP:0030345Abnormal circulating luteinizing hormone concentration1DHX37 CL E G H5764717210OMIM:27325046, XY sex reversal 112
HP:0030338HP:0000837Increased circulating gonadotropin level1DHX37 CL E G H5764717210OMIM:27325046, XY sex reversal 112
HP:0030338HP:0030345Abnormal circulating luteinizing hormone concentration1DHX37 CL E G H5764717210ORPHA:25151046,XY partial gonadal dysgenesis2
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1DHX37 CL E G H5764717210ORPHA:25151046,XY partial gonadal dysgenesis2
HP:0030338HP:0000837Increased circulating gonadotropin level1DHX37 CL E G H5764717210ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent2
HP:0030338HP:0030345Abnormal circulating luteinizing hormone concentration1DIAPH2 CL E G H17302877OMIM:300511Premature ovarian failure 2A6
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1DIAPH2 CL E G H17302877OMIM:300511Premature ovarian failure 2A6
HP:0030338HP:0000837Increased circulating gonadotropin level1DIAPH2 CL E G H17302877OMIM:300511Premature ovarian failure 2A6
HP:0030338HP:0000837Increased circulating gonadotropin level1DMRT3 CL E G H5852413909ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent1
HP:0030338HP:0030345Abnormal circulating luteinizing hormone concentration1DMRT3 CL E G H5852413909ORPHA:25151046,XY partial gonadal dysgenesis1
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1DMRT3 CL E G H5852413909ORPHA:25151046,XY partial gonadal dysgenesis1
HP:0030338HP:0030339Decreased circulating gonadotropin concentration1DMXL2 CL E G H233122938ORPHA:453533Polyendocrine-polyneuropathy syndrome3
HP:0030338HP:0030345Abnormal circulating luteinizing hormone concentration1DMXL2 CL E G H233122938ORPHA:453533Polyendocrine-polyneuropathy syndrome3
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1DMXL2 CL E G H233122938ORPHA:453533Polyendocrine-polyneuropathy syndrome3
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1ERCC6 CL E G H20743438OMIM:616946PREMATURE OVARIAN FAILURE 11; POF11199
HP:0030338HP:0000837Increased circulating gonadotropin level1ERCC6 CL E G H20743438OMIM:616946PREMATURE OVARIAN FAILURE 11; POF11199
HP:0030338HP:0000837Increased circulating gonadotropin level1ESR1 CL E G H20993467ORPHA:785Estrogen resistance syndromeHP:0040281 - Very frequent13
HP:0030338HP:0030345Abnormal circulating luteinizing hormone concentration1ESR2 CL E G H21003468OMIM:618187Ovarian dysgenesis 8
HP:0030338HP:0000837Increased circulating gonadotropin level1ESR2 CL E G H21003468OMIM:618187Ovarian dysgenesis 8
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1ESR2 CL E G H21003468OMIM:618187Ovarian dysgenesis 8
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1FAM111A CL E G H6390124725ORPHA:93325Autosomal dominant Kenny-Caffey syndromeHP:0040282 - Frequent8
HP:0030338HP:0000837Increased circulating gonadotropin level1FANCM CL E G H5769723168ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutationHP:0040281 - Very frequent107
HP:0030338HP:0000837Increased circulating gonadotropin level1FANCM CL E G H5769723168OMIM:618086Spermatogenic failure 28107
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1FANCM CL E G H5769723168OMIM:618086Spermatogenic failure 28107
HP:0030338HP:0030345Abnormal circulating luteinizing hormone concentration1FANCM CL E G H5769723168OMIM:618086Spermatogenic failure 28107
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1FGD1 CL E G H22453663OMIM:305400Aarskog-Scott syndrome62
HP:0030338HP:0030345Abnormal circulating luteinizing hormone concentration1FGD1 CL E G H22453663OMIM:305400Aarskog-Scott syndrome62
HP:0030338HP:0000837Increased circulating gonadotropin level1FGD1 CL E G H22453663OMIM:305400Aarskog-Scott syndrome62
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1FIGLA CL E G H34401824669OMIM:612310PREMATURE OVARIAN FAILURE 6; POF617
HP:0030338HP:0000837Increased circulating gonadotropin level1FIGLA CL E G H34401824669OMIM:612310PREMATURE OVARIAN FAILURE 6; POF617
HP:0030338HP:0030345Abnormal circulating luteinizing hormone concentration1FIGLA CL E G H34401824669OMIM:612310PREMATURE OVARIAN FAILURE 6; POF617
HP:0030338HP:0000837Increased circulating gonadotropin level1FKBP6 CL E G H84683722OMIM:620103
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1FKBP6 CL E G H84683722OMIM:620103
HP:0030338HP:0000837Increased circulating gonadotropin level1FMR1 CL E G H23323775OMIM:311360Premature ovarian failure 1.30
HP:0030338HP:0000837Increased circulating gonadotropin level1FOXL2 CL E G H6681092OMIM:110100Blepharophimosis, epicanthus inversus, and ptosis.92
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1FOXL2 CL E G H6681092ORPHA:572333Blepharophimosis-ptosis-epicanthus inversus syndrome plus92
HP:0030338HP:0000837Increased circulating gonadotropin level1FOXL2 CL E G H6681092ORPHA:572333Blepharophimosis-ptosis-epicanthus inversus syndrome plus92
HP:0030338HP:0030345Abnormal circulating luteinizing hormone concentration1FOXL2 CL E G H6681092ORPHA:572333Blepharophimosis-ptosis-epicanthus inversus syndrome plus92
HP:0030338HP:0000837Increased circulating gonadotropin level1FSHB CL E G H24883964OMIM:229070Hypogonadotropic hypogonadism 24 without anosmia23
HP:0030338HP:0030339Decreased circulating gonadotropin concentration1FSHB CL E G H24883964OMIM:229070Hypogonadotropic hypogonadism 24 without anosmia23
HP:0030338HP:0030345Abnormal circulating luteinizing hormone concentration1FSHB CL E G H24883964OMIM:229070Hypogonadotropic hypogonadism 24 without anosmia23
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1FSHB CL E G H24883964OMIM:229070Hypogonadotropic hypogonadism 24 without anosmia23
HP:0030338HP:0000837Increased circulating gonadotropin level1FSHR CL E G H24923969ORPHA:24346,XX gonadal dysgenesisHP:0040281 - Very frequent50
HP:0030338HP:0000837Increased circulating gonadotropin level1FSHR CL E G H24923969OMIM:233300Ovarian dysgenesis 1.50
HP:0030338HP:0000837Increased circulating gonadotropin level1FSHR CL E G H24923969ORPHA:64739Ovarian hyperstimulation syndromeHP:0040281 - Very frequent50
HP:0030338HP:0000837Increased circulating gonadotropin level1GATA4 CL E G H26264173ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent87
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1GATA4 CL E G H26264173ORPHA:25151046,XY partial gonadal dysgenesis87
HP:0030338HP:0030345Abnormal circulating luteinizing hormone concentration1GATA4 CL E G H26264173ORPHA:25151046,XY partial gonadal dysgenesis87
HP:0030338HP:0030345Abnormal circulating luteinizing hormone concentration1GCNA CL E G H9395315805OMIM:301077SPERMATOGENIC FAILURE, X-LINKED, 4; SPGFX4
HP:0030338HP:0000837Increased circulating gonadotropin level1GCNA CL E G H9395315805OMIM:301077SPERMATOGENIC FAILURE, X-LINKED, 4; SPGFX4
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1GCNA CL E G H9395315805OMIM:301077SPERMATOGENIC FAILURE, X-LINKED, 4; SPGFX4
HP:0030338HP:0030345Abnormal circulating luteinizing hormone concentration1GDF9 CL E G H26614224OMIM:618014Premature ovarian failure 142
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1GDF9 CL E G H26614224OMIM:618014Premature ovarian failure 142
HP:0030338HP:0000837Increased circulating gonadotropin level1GDF9 CL E G H26614224OMIM:618014Premature ovarian failure 142
HP:0030338HP:0030339Decreased circulating gonadotropin concentration1GNRH1 CL E G H27964419OMIM:614841Hypogonadotropic hypogonadism 12 with or without anosmia.15
HP:0030338HP:0030339Decreased circulating gonadotropin concentration1HESX1 CL E G H88204877ORPHA:226307Hypothyroidism due to deficient transcription factors involved in pituitary development or function21
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1HESX1 CL E G H88204877ORPHA:226307Hypothyroidism due to deficient transcription factors involved in pituitary development or function21
HP:0030338HP:0030345Abnormal circulating luteinizing hormone concentration1HESX1 CL E G H88204877ORPHA:226307Hypothyroidism due to deficient transcription factors involved in pituitary development or function21
HP:0030338HP:0000837Increased circulating gonadotropin level1HFM1 CL E G H16404520193OMIM:615724Premature ovarian failure 9.6
HP:0030338HP:0000837Increased circulating gonadotropin level1HSD17B4 CL E G H32955213OMIM:233400Perrault syndrome 1.98
HP:0030338HP:0030345Abnormal circulating luteinizing hormone concentration1KISS1 CL E G H38146341OMIM:614842Hypogonadotropic hypogonadism 13 with or without anosmia3
HP:0030338HP:0030339Decreased circulating gonadotropin concentration1KISS1 CL E G H38146341OMIM:614842Hypogonadotropic hypogonadism 13 with or without anosmia3
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1KISS1 CL E G H38146341OMIM:614842Hypogonadotropic hypogonadism 13 with or without anosmia3
HP:0030338HP:0000837Increased circulating gonadotropin level1KISS1R CL E G H846344510OMIM:176400Precocious puberty, central14
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1KISS1R CL E G H846344510OMIM:176400Precocious puberty, central14
HP:0030338HP:0030345Abnormal circulating luteinizing hormone concentration1KISS1R CL E G H846344510OMIM:176400Precocious puberty, central14
HP:0030338HP:0000837Increased circulating gonadotropin level1KLHL10 CL E G H31771918829ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutationHP:0040281 - Very frequent3
HP:0030338HP:0000837Increased circulating gonadotropin level1LARS2 CL E G H2339517095OMIM:615300Perrault syndrome 454
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1LGR4 CL E G H5536613299OMIM:619613DELAYED PUBERTY, SELF-LIMITED; DPSL1
HP:0030338HP:0030339Decreased circulating gonadotropin concentration1LGR4 CL E G H5536613299OMIM:619613DELAYED PUBERTY, SELF-LIMITED; DPSL1
HP:0030338HP:0030345Abnormal circulating luteinizing hormone concentration1LGR4 CL E G H5536613299OMIM:619613DELAYED PUBERTY, SELF-LIMITED; DPSL1
HP:0030338HP:0030339Decreased circulating gonadotropin concentration1LHB CL E G H39726584OMIM:228300Hypogonadotropic hypogonadism 23 without anosmia9
HP:0030338HP:0000837Increased circulating gonadotropin level1LHB CL E G H39726584OMIM:228300Hypogonadotropic hypogonadism 23 without anosmia9
HP:0030338HP:0030345Abnormal circulating luteinizing hormone concentration1LHB CL E G H39726584OMIM:228300Hypogonadotropic hypogonadism 23 without anosmia9
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1LHB CL E G H39726584OMIM:228300Hypogonadotropic hypogonadism 23 without anosmia9
HP:0030338HP:0000837Increased circulating gonadotropin level1LHCGR CL E G H39736585OMIM:238320Hypergonadotropic hypogonadism.67
HP:0030338HP:0030339Decreased circulating gonadotropin concentration1LHX3 CL E G H80226595ORPHA:226307Hypothyroidism due to deficient transcription factors involved in pituitary development or function51
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1LHX3 CL E G H80226595ORPHA:226307Hypothyroidism due to deficient transcription factors involved in pituitary development or function51
HP:0030338HP:0030345Abnormal circulating luteinizing hormone concentration1LHX3 CL E G H80226595ORPHA:226307Hypothyroidism due to deficient transcription factors involved in pituitary development or function51
HP:0030338HP:0030345Abnormal circulating luteinizing hormone concentration1LHX4 CL E G H8988421734ORPHA:226307Hypothyroidism due to deficient transcription factors involved in pituitary development or function43
HP:0030338HP:0030339Decreased circulating gonadotropin concentration1LHX4 CL E G H8988421734ORPHA:226307Hypothyroidism due to deficient transcription factors involved in pituitary development or function43
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1LHX4 CL E G H8988421734ORPHA:226307Hypothyroidism due to deficient transcription factors involved in pituitary development or function43
HP:0030338HP:0030339Decreased circulating gonadotropin concentration1MAGEL2 CL E G H545516814ORPHA:98754Prader-Willi syndrome due to maternal uniparental disomy of chromosome 15HP:0040282 - Frequent63
HP:0030338HP:0030339Decreased circulating gonadotropin concentration1MAGEL2 CL E G H545516814ORPHA:177901Prader-Willi syndrome due to paternal deletion of 15q11q13 type 1HP:0040282 - Frequent63
HP:0030338HP:0030339Decreased circulating gonadotropin concentration1MAGEL2 CL E G H545516814ORPHA:177904Prader-Willi syndrome due to paternal deletion of 15q11q13 type 2HP:0040282 - Frequent63
HP:0030338HP:0000837Increased circulating gonadotropin level1MAP3K1 CL E G H42146848ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent13
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1MAP3K1 CL E G H42146848ORPHA:25151046,XY partial gonadal dysgenesis13
HP:0030338HP:0030345Abnormal circulating luteinizing hormone concentration1MAP3K1 CL E G H42146848ORPHA:25151046,XY partial gonadal dysgenesis13
HP:0030338HP:0000837Increased circulating gonadotropin level1MCM8 CL E G H8451516147OMIM:612885Premature ovarian failure 104
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1MCM8 CL E G H8451516147OMIM:612885Premature ovarian failure 104
HP:0030338HP:0030345Abnormal circulating luteinizing hormone concentration1MCM8 CL E G H8451516147OMIM:612885Premature ovarian failure 104
HP:0030338HP:0000837Increased circulating gonadotropin level1MCM9 CL E G H25439421484OMIM:616185Ovarian dysgenesis 44
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1MCM9 CL E G H25439421484OMIM:616185Ovarian dysgenesis 44
HP:0030338HP:0000837Increased circulating gonadotropin level1MEIOB CL E G H25452828569ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutationHP:0040281 - Very frequent
HP:0030338HP:0000837Increased circulating gonadotropin level1MRPS22 CL E G H5694514508ORPHA:24346,XX gonadal dysgenesisHP:0040281 - Very frequent25
HP:0030338HP:0000837Increased circulating gonadotropin level1MSH4 CL E G H44387327OMIM:619938
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1MSH4 CL E G H44387327OMIM:619938
HP:0030338HP:0030345Abnormal circulating luteinizing hormone concentration1MSH4 CL E G H44387327OMIM:619938
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1MSH5 CL E G H44397328OMIM:617442Premature ovarian failure 135
HP:0030338HP:0000837Increased circulating gonadotropin level1MSH5 CL E G H44397328OMIM:617442Premature ovarian failure 135
HP:0030338HP:0000837Increased circulating gonadotropin level1NANOS1 CL E G H34071923044ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutationHP:0040281 - Very frequent4
HP:0030338HP:0000837Increased circulating gonadotropin level1NANOS1 CL E G H34071923044ORPHA:399808Male infertility with teratozoospermia due to single gene mutationHP:0040281 - Very frequent4
HP:0030338HP:0030339Decreased circulating gonadotropin concentration1NDN CL E G H46927675ORPHA:98754Prader-Willi syndrome due to maternal uniparental disomy of chromosome 15HP:0040282 - Frequent
HP:0030338HP:0030339Decreased circulating gonadotropin concentration1NDN CL E G H46927675ORPHA:177901Prader-Willi syndrome due to paternal deletion of 15q11q13 type 1HP:0040282 - Frequent
HP:0030338HP:0030339Decreased circulating gonadotropin concentration1NDN CL E G H46927675ORPHA:177904Prader-Willi syndrome due to paternal deletion of 15q11q13 type 2HP:0040282 - Frequent
HP:0030338HP:0030345Abnormal circulating luteinizing hormone concentration1NF2 CL E G H47717773ORPHA:2495Meningioma220
HP:0030338HP:0030339Decreased circulating gonadotropin concentration1NF2 CL E G H47717773ORPHA:2495Meningioma220
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1NF2 CL E G H47717773ORPHA:2495Meningioma220
HP:0030338HP:0030345Abnormal circulating luteinizing hormone concentration1NHLH2 CL E G H48087818OMIM:619755HYPOGONADOTROPIC HYPOGONADISM 27 WITHOUT ANOSMIA; HH27
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1NHLH2 CL E G H48087818OMIM:619755HYPOGONADOTROPIC HYPOGONADISM 27 WITHOUT ANOSMIA; HH27
HP:0030338HP:0030339Decreased circulating gonadotropin concentration1NHLH2 CL E G H48087818OMIM:619755HYPOGONADOTROPIC HYPOGONADISM 27 WITHOUT ANOSMIA; HH27
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1NR0B1 CL E G H1907960ORPHA:25151046,XY partial gonadal dysgenesis48
HP:0030338HP:0000837Increased circulating gonadotropin level1NR0B1 CL E G H1907960ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent48
HP:0030338HP:0030345Abnormal circulating luteinizing hormone concentration1NR0B1 CL E G H1907960ORPHA:25151046,XY partial gonadal dysgenesis48
HP:0030338HP:0000837Increased circulating gonadotropin level1NR5A1 CL E G H25167983ORPHA:24346,XX gonadal dysgenesisHP:0040281 - Very frequent38
HP:0030338HP:0000837Increased circulating gonadotropin level1NR5A1 CL E G H25167983ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent38
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1NR5A1 CL E G H25167983ORPHA:25151046,XY partial gonadal dysgenesis38
HP:0030338HP:0030345Abnormal circulating luteinizing hormone concentration1NR5A1 CL E G H25167983ORPHA:25151046,XY partial gonadal dysgenesis38
HP:0030338HP:0000837Increased circulating gonadotropin level1NR5A1 CL E G H25167983OMIM:61296546XY sex reversal 338
HP:0030338HP:0030345Abnormal circulating luteinizing hormone concentration1NR5A1 CL E G H25167983OMIM:61296546XY sex reversal 338
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1NR5A1 CL E G H25167983OMIM:61296546XY sex reversal 338
HP:0030338HP:0000837Increased circulating gonadotropin level1NR5A1 CL E G H25167983ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutationHP:0040281 - Very frequent38
HP:0030338HP:0000837Increased circulating gonadotropin level1NR5A1 CL E G H25167983OMIM:612964PREMATURE OVARIAN FAILURE 7; POF738
HP:0030338HP:0030345Abnormal circulating luteinizing hormone concentration1NR5A1 CL E G H25167983OMIM:612964PREMATURE OVARIAN FAILURE 7; POF738
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1NR5A1 CL E G H25167983OMIM:612964PREMATURE OVARIAN FAILURE 7; POF738
HP:0030338HP:0000837Increased circulating gonadotropin level1NSMCE2 CL E G H28605326513OMIM:617253Seckel syndrome 102
HP:0030338HP:0030345Abnormal circulating luteinizing hormone concentration1NSMCE2 CL E G H28605326513OMIM:617253Seckel syndrome 102
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1NSMCE2 CL E G H28605326513OMIM:617253Seckel syndrome 102
HP:0030338HP:0000837Increased circulating gonadotropin level1NUP107 CL E G H5712229914ORPHA:24346,XX gonadal dysgenesisHP:0040281 - Very frequent5
HP:0030338HP:0030339Decreased circulating gonadotropin concentration1OCA2 CL E G H49488101ORPHA:98754Prader-Willi syndrome due to maternal uniparental disomy of chromosome 15HP:0040282 - Frequent121
HP:0030338HP:0030339Decreased circulating gonadotropin concentration1OCA2 CL E G H49488101ORPHA:177901Prader-Willi syndrome due to paternal deletion of 15q11q13 type 1HP:0040282 - Frequent121
HP:0030338HP:0030339Decreased circulating gonadotropin concentration1OCA2 CL E G H49488101ORPHA:177904Prader-Willi syndrome due to paternal deletion of 15q11q13 type 2HP:0040282 - Frequent121
HP:0030338HP:0030339Decreased circulating gonadotropin concentration1OTX2 CL E G H50158522OMIM:613986Pituitary hormone deficiency, combined, 641
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1OTX2 CL E G H50158522OMIM:613986Pituitary hormone deficiency, combined, 641
HP:0030338HP:0030345Abnormal circulating luteinizing hormone concentration1OTX2 CL E G H50158522OMIM:613986Pituitary hormone deficiency, combined, 641
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1PDGFB CL E G H51558800ORPHA:2495Meningioma9
HP:0030338HP:0030345Abnormal circulating luteinizing hormone concentration1PDGFB CL E G H51558800ORPHA:2495Meningioma9
HP:0030338HP:0030339Decreased circulating gonadotropin concentration1PDGFB CL E G H51558800ORPHA:2495Meningioma9
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1PIK3CA CL E G H52908975ORPHA:2495Meningioma162
HP:0030338HP:0030345Abnormal circulating luteinizing hormone concentration1PIK3CA CL E G H52908975ORPHA:2495Meningioma162
HP:0030338HP:0030339Decreased circulating gonadotropin concentration1PIK3CA CL E G H52908975ORPHA:2495Meningioma162
HP:0030338HP:0000837Increased circulating gonadotropin level1PNLDC1 CL E G H15419721185ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutationHP:0040281 - Very frequent
HP:0030338HP:0030339Decreased circulating gonadotropin concentration1PNPLA6 CL E G H1090816268OMIM:215470Boucher-Neuhauser syndrome103
HP:0030338HP:0000837Increased circulating gonadotropin level1POLA1 CL E G H54229173ORPHA:163976X-linked intellectual disability, Van Esch typeHP:0040282 - Frequent2
HP:0030338HP:0000837Increased circulating gonadotropin level1POLR3H CL E G H17156830349ORPHA:24346,XX gonadal dysgenesisHP:0040281 - Very frequent
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1POR CL E G H54479208ORPHA:95699Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency76
HP:0030338HP:0000837Increased circulating gonadotropin level1POR CL E G H54479208ORPHA:95699Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency76
HP:0030338HP:0030345Abnormal circulating luteinizing hormone concentration1POR CL E G H54479208ORPHA:95699Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency76
HP:0030338HP:0030339Decreased circulating gonadotropin concentration1POU1F1 CL E G H54499210ORPHA:226307Hypothyroidism due to deficient transcription factors involved in pituitary development or function36
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1POU1F1 CL E G H54499210ORPHA:226307Hypothyroidism due to deficient transcription factors involved in pituitary development or function36
HP:0030338HP:0030345Abnormal circulating luteinizing hormone concentration1POU1F1 CL E G H54499210ORPHA:226307Hypothyroidism due to deficient transcription factors involved in pituitary development or function36
HP:0030338HP:0030345Abnormal circulating luteinizing hormone concentration1PPP2R3C CL E G H5501217485OMIM:618419Gonadal dysgenesis, dysmorphic facies, retinal dystrophy, and myopathy
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1PPP2R3C CL E G H5501217485OMIM:618419Gonadal dysgenesis, dysmorphic facies, retinal dystrophy, and myopathy
HP:0030338HP:0000837Increased circulating gonadotropin level1PPP2R3C CL E G H5501217485OMIM:618419Gonadal dysgenesis, dysmorphic facies, retinal dystrophy, and myopathy
HP:0030338HP:0030339Decreased circulating gonadotropin concentration1PRDM13 CL E G H5933613998OMIM:619761CEREBELLAR DYSFUNCTION, IMPAIRED INTELLECTUAL DEVELOPMENT, AND HYPOGONADOTROPIC HYPOGONADISM; CDIDHH2
HP:0030338HP:0030345Abnormal circulating luteinizing hormone concentration1PRDM13 CL E G H5933613998OMIM:619761CEREBELLAR DYSFUNCTION, IMPAIRED INTELLECTUAL DEVELOPMENT, AND HYPOGONADOTROPIC HYPOGONADISM; CDIDHH2
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1PRDM13 CL E G H5933613998OMIM:619761CEREBELLAR DYSFUNCTION, IMPAIRED INTELLECTUAL DEVELOPMENT, AND HYPOGONADOTROPIC HYPOGONADISM; CDIDHH2
HP:0030338HP:0030339Decreased circulating gonadotropin concentration1PROP1 CL E G H56269455ORPHA:226307Hypothyroidism due to deficient transcription factors involved in pituitary development or function54
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1PROP1 CL E G H56269455ORPHA:226307Hypothyroidism due to deficient transcription factors involved in pituitary development or function54
HP:0030338HP:0030345Abnormal circulating luteinizing hormone concentration1PROP1 CL E G H56269455ORPHA:226307Hypothyroidism due to deficient transcription factors involved in pituitary development or function54
HP:0030338HP:0000837Increased circulating gonadotropin level1PSMC3IP CL E G H2989317928ORPHA:24346,XX gonadal dysgenesisHP:0040281 - Very frequent2
HP:0030338HP:0030345Abnormal circulating luteinizing hormone concentration1PSMC3IP CL E G H2989317928OMIM:614324Ovarian dysgenesis 32
HP:0030338HP:0000837Increased circulating gonadotropin level1PSMC3IP CL E G H2989317928OMIM:614324Ovarian dysgenesis 32
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1PSMC3IP CL E G H2989317928OMIM:614324Ovarian dysgenesis 32
HP:0030338HP:0030339Decreased circulating gonadotropin concentration1SEMA3A CL E G H1037110723OMIM:614897Hypogonadotropic hypogonadism 16 with or without anosmia14
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1SEMA3A CL E G H1037110723OMIM:614897Hypogonadotropic hypogonadism 16 with or without anosmia14
HP:0030338HP:0030345Abnormal circulating luteinizing hormone concentration1SEMA3A CL E G H1037110723OMIM:614897Hypogonadotropic hypogonadism 16 with or without anosmia14
HP:0030338HP:0000837Increased circulating gonadotropin level1SHOC1 CL E G H15840126535OMIM:619949
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1SHOC1 CL E G H15840126535OMIM:619949
HP:0030338HP:0030339Decreased circulating gonadotropin concentration1SMARCB1 CL E G H659811103ORPHA:2495Meningioma87
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1SMARCB1 CL E G H659811103ORPHA:2495Meningioma87
HP:0030338HP:0030345Abnormal circulating luteinizing hormone concentration1SMARCB1 CL E G H659811103ORPHA:2495Meningioma87
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1SMARCE1 CL E G H660511109ORPHA:2495Meningioma47
HP:0030338HP:0030345Abnormal circulating luteinizing hormone concentration1SMARCE1 CL E G H660511109ORPHA:2495Meningioma47
HP:0030338HP:0030339Decreased circulating gonadotropin concentration1SMARCE1 CL E G H660511109ORPHA:2495Meningioma47
HP:0030338HP:0030339Decreased circulating gonadotropin concentration1SMO CL E G H660811119ORPHA:2495Meningioma22
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1SMO CL E G H660811119ORPHA:2495Meningioma22
HP:0030338HP:0030345Abnormal circulating luteinizing hormone concentration1SMO CL E G H660811119ORPHA:2495Meningioma22
HP:0030338HP:0030339Decreased circulating gonadotropin concentration1SNRPN CL E G H663811164ORPHA:98754Prader-Willi syndrome due to maternal uniparental disomy of chromosome 15HP:0040282 - Frequent37
HP:0030338HP:0030339Decreased circulating gonadotropin concentration1SNRPN CL E G H663811164ORPHA:177901Prader-Willi syndrome due to paternal deletion of 15q11q13 type 1HP:0040282 - Frequent37
HP:0030338HP:0030339Decreased circulating gonadotropin concentration1SNRPN CL E G H663811164ORPHA:177904Prader-Willi syndrome due to paternal deletion of 15q11q13 type 2HP:0040282 - Frequent37
HP:0030338HP:0000837Increased circulating gonadotropin level1SOHLH1 CL E G H40238127845ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutationHP:0040281 - Very frequent3
HP:0030338HP:0000837Increased circulating gonadotropin level1SOX9 CL E G H666211204ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent109
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1SOX9 CL E G H666211204ORPHA:25151046,XY partial gonadal dysgenesis109
HP:0030338HP:0030345Abnormal circulating luteinizing hormone concentration1SOX9 CL E G H666211204ORPHA:25151046,XY partial gonadal dysgenesis109
HP:0030338HP:0000837Increased circulating gonadotropin level1SPIDR CL E G H2351428971ORPHA:24346,XX gonadal dysgenesisHP:0040281 - Very frequent2
HP:0030338HP:0000837Increased circulating gonadotropin level1SPIDR CL E G H2351428971OMIM:619665OVARIAN DYSGENESIS 9; ODG92
HP:0030338HP:0030345Abnormal circulating luteinizing hormone concentration1SPIDR CL E G H2351428971OMIM:619665OVARIAN DYSGENESIS 9; ODG92
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1SPIDR CL E G H2351428971OMIM:619665OVARIAN DYSGENESIS 9; ODG92
HP:0030338HP:0000837Increased circulating gonadotropin level1SRY CL E G H673611311ORPHA:177245,X/46,XY mixed gonadal dysgenesisHP:0040282 - Frequent23
HP:0030338HP:0000837Increased circulating gonadotropin level1SRY CL E G H673611311ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent23
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1SRY CL E G H673611311ORPHA:25151046,XY partial gonadal dysgenesis23
HP:0030338HP:0030345Abnormal circulating luteinizing hormone concentration1SRY CL E G H673611311ORPHA:25151046,XY partial gonadal dysgenesis23
HP:0030338HP:0030345Abnormal circulating luteinizing hormone concentration1SRY CL E G H673611311OMIM:40004546XX sex reversal 123
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1SRY CL E G H673611311OMIM:40004546XX sex reversal 123
HP:0030338HP:0000837Increased circulating gonadotropin level1SRY CL E G H673611311OMIM:40004546XX sex reversal 123
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1SRY CL E G H673611311OMIM:40004446XY sex reversal 123
HP:0030338HP:0000837Increased circulating gonadotropin level1SRY CL E G H673611311OMIM:40004446XY sex reversal 123
HP:0030338HP:0030345Abnormal circulating luteinizing hormone concentration1SRY CL E G H673611311OMIM:40004446XY sex reversal 123
HP:0030338HP:0030345Abnormal circulating luteinizing hormone concentration1STAG3 CL E G H1073411356OMIM:615723Premature ovarian failure 84
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1STAG3 CL E G H1073411356OMIM:615723Premature ovarian failure 84
HP:0030338HP:0000837Increased circulating gonadotropin level1STAG3 CL E G H1073411356OMIM:615723Premature ovarian failure 8.4
HP:0030338HP:0030345Abnormal circulating luteinizing hormone concentration1SUFU CL E G H5168416466ORPHA:2495Meningioma124
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1SUFU CL E G H5168416466ORPHA:2495Meningioma124
HP:0030338HP:0030339Decreased circulating gonadotropin concentration1SUFU CL E G H5168416466ORPHA:2495Meningioma124
HP:0030338HP:0000837Increased circulating gonadotropin level1SYCE1 CL E G H9342628852ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutationHP:0040281 - Very frequent4
HP:0030338HP:0000837Increased circulating gonadotropin level1SYCP3 CL E G H5051118130ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutationHP:0040281 - Very frequent12
HP:0030338HP:0000837Increased circulating gonadotropin level1TAF4B CL E G H687511538ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutationHP:0040281 - Very frequent1
HP:0030338HP:0000837Increased circulating gonadotropin level1TDRD9 CL E G H12240220122ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutationHP:0040281 - Very frequent
HP:0030338HP:0030345Abnormal circulating luteinizing hormone concentration1TERT CL E G H701511730ORPHA:2495Meningioma238
HP:0030338HP:0030339Decreased circulating gonadotropin concentration1TERT CL E G H701511730ORPHA:2495Meningioma238
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1TERT CL E G H701511730ORPHA:2495Meningioma238
HP:0030338HP:0000837Increased circulating gonadotropin level1TEX11 CL E G H5615911733ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutationHP:0040281 - Very frequent5
HP:0030338HP:0000837Increased circulating gonadotropin level1TEX14 CL E G H5615511737ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutationHP:0040281 - Very frequent1
HP:0030338HP:0000837Increased circulating gonadotropin level1TEX15 CL E G H5615411738ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutationHP:0040281 - Very frequent1
HP:0030338HP:0030339Decreased circulating gonadotropin concentration1TRAF7 CL E G H8423120456ORPHA:2495Meningioma
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1TRAF7 CL E G H8423120456ORPHA:2495Meningioma
HP:0030338HP:0030345Abnormal circulating luteinizing hormone concentration1TRAF7 CL E G H8423120456ORPHA:2495Meningioma
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1VAMP7 CL E G H684511486ORPHA:25151046,XY partial gonadal dysgenesis2
HP:0030338HP:0030345Abnormal circulating luteinizing hormone concentration1VAMP7 CL E G H684511486ORPHA:25151046,XY partial gonadal dysgenesis2
HP:0030338HP:0000837Increased circulating gonadotropin level1VAMP7 CL E G H684511486ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent2
HP:0030338HP:0000837Increased circulating gonadotropin level1WT1 CL E G H749012796ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent177
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1WT1 CL E G H749012796ORPHA:25151046,XY partial gonadal dysgenesis177
HP:0030338HP:0030345Abnormal circulating luteinizing hormone concentration1WT1 CL E G H749012796ORPHA:25151046,XY partial gonadal dysgenesis177
HP:0030338HP:0000837Increased circulating gonadotropin level1WT1 CL E G H749012796ORPHA:347Frasier syndromeHP:0040281 - Very frequent177
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1WWOX CL E G H5174112799ORPHA:25151046,XY partial gonadal dysgenesis149
HP:0030338HP:0030345Abnormal circulating luteinizing hormone concentration1WWOX CL E G H5174112799ORPHA:25151046,XY partial gonadal dysgenesis149
HP:0030338HP:0000837Increased circulating gonadotropin level1WWOX CL E G H5174112799ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent149
HP:0030338HP:0000837Increased circulating gonadotropin level1XRCC2 CL E G H751612829ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutationHP:0040281 - Very frequent125
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1XRCC2 CL E G H751612829OMIM:619146PREMATURE OVARIAN FAILURE 17; POF17125
HP:0030338HP:0000837Increased circulating gonadotropin level1XRCC2 CL E G H751612829OMIM:619146PREMATURE OVARIAN FAILURE 17; POF17125
HP:0030338HP:0030345Abnormal circulating luteinizing hormone concentration1XRCC2 CL E G H751612829OMIM:619146PREMATURE OVARIAN FAILURE 17; POF17125
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1ZFPM2 CL E G H2341416700ORPHA:25151046,XY partial gonadal dysgenesis31
HP:0030338HP:0000837Increased circulating gonadotropin level1ZFPM2 CL E G H2341416700ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent31
HP:0030338HP:0030345Abnormal circulating luteinizing hormone concentration1ZFPM2 CL E G H2341416700ORPHA:25151046,XY partial gonadal dysgenesis31
HP:0030338HP:0000837Increased circulating gonadotropin level1ZMYND15 CL E G H8422520997ORPHA:399805Male infertility with azoospermia or oligozoospermia due to single gene mutationHP:0040281 - Very frequent1
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1ZMYND15 CL E G H8422520997OMIM:615842Spermatogenic failure 141
HP:0030338HP:0000837Increased circulating gonadotropin level1ZMYND15 CL E G H8422520997OMIM:615842Spermatogenic failure 141
HP:0030338HP:0000837Increased circulating gonadotropin level1ZSWIM7 CL E G H12515026993ORPHA:24346,XX gonadal dysgenesisHP:0040281 - Very frequent
HP:0030338HP:0000837Increased circulating gonadotropin level1ZSWIM7 CL E G H12515026993OMIM:619834OVARIAN DYSGENESIS 10; ODG10
HP:0030338HP:0030345Abnormal circulating luteinizing hormone concentration1ZSWIM7 CL E G H12515026993OMIM:619834OVARIAN DYSGENESIS 10; ODG10
HP:0030338HP:0030346Abnormal circulating follicle-stimulating hormone concentration1ZSWIM7 CL E G H12515026993OMIM:619834OVARIAN DYSGENESIS 10; ODG10
HP:0030338HP:0030341Decreased circulating follicle stimulating hormone concentration2AKT1 CL E G H207391ORPHA:2495MeningiomaHP:0040282 - Frequent54
HP:0030338HP:0030344Decreased circulating luteinizing hormone level2AKT1 CL E G H207391ORPHA:2495MeningiomaHP:0040282 - Frequent54
HP:0030338HP:0030344Decreased circulating luteinizing hormone level2ANOS1 CL E G H37306211OMIM:308700Hypogonadotropic hypogonadism 1 with or without anosmia65
HP:0030338HP:0030341Decreased circulating follicle stimulating hormone concentration2ANOS1 CL E G H37306211OMIM:308700Hypogonadotropic hypogonadism 1 with or without anosmia65
HP:0030338HP:0008232Elevated circulating follicle stimulating hormone level2AR CL E G H367644OMIM:300068Androgen insensitivity syndrome.125
HP:0030338HP:0011969Elevated circulating luteinizing hormone level2AR CL E G H367644OMIM:300068Androgen insensitivity syndrome.125
HP:0030338HP:0011969Elevated circulating luteinizing hormone level2AR CL E G H367644ORPHA:99429Complete androgen insensitivity syndromeHP:0040281 - Very frequent125
HP:0030338HP:0011969Elevated circulating luteinizing hormone level2AR CL E G H367644ORPHA:90797Partial androgen insensitivity syndromeHP:0040281 - Very frequent125
HP:0030338HP:0030344Decreased circulating luteinizing hormone level2BAP1 CL E G H8314950ORPHA:2495MeningiomaHP:0040282 - Frequent184
HP:0030338HP:0030341Decreased circulating follicle stimulating hormone concentration2BAP1 CL E G H8314950ORPHA:2495MeningiomaHP:0040282 - Frequent184
HP:0030338HP:0008232Elevated circulating follicle stimulating hormone level2BMPR1B CL E G H6581077OMIM:609441Acromesomelic dysplasia, Demirhan type90
HP:0030338HP:0011969Elevated circulating luteinizing hormone level2BMPR1B CL E G H6581077OMIM:609441Acromesomelic dysplasia, Demirhan type90
HP:0030338HP:0008232Elevated circulating follicle stimulating hormone level2BNC1 CL E G H6461081OMIM:618723PREMATURE OVARIAN FAILURE 16; POF16
HP:0030338HP:0011969Elevated circulating luteinizing hormone level2C14ORF39 CL E G H31776119849OMIM:619203PREMATURE OVARIAN FAILURE 18; POF18
HP:0030338HP:0008232Elevated circulating follicle stimulating hormone level2C14ORF39 CL E G H31776119849OMIM:619203PREMATURE OVARIAN FAILURE 18; POF18
HP:0030338HP:0008232Elevated circulating follicle stimulating hormone level2CBX2 CL E G H847331552OMIM:61308046XY sex reversal 5.3
HP:0030338HP:0008232Elevated circulating follicle stimulating hormone level2CNBP CL E G H755513164OMIM:602668Dystrophia myotonica 2.1
HP:0030338HP:0030341Decreased circulating follicle stimulating hormone concentration2CPE CL E G H13632303OMIM:619326BDV SYNDROME; BDVS
HP:0030338HP:0008232Elevated circulating follicle stimulating hormone level2CYB5A CL E G H15282570ORPHA:9079646,XY disorder of sex development due to isolated 17,20-lyase deficiencyHP:0040281 - Very frequent2
HP:0030338HP:0011969Elevated circulating luteinizing hormone level2CYB5A CL E G H15282570ORPHA:9079646,XY disorder of sex development due to isolated 17,20-lyase deficiencyHP:0040281 - Very frequent2
HP:0030338HP:0008232Elevated circulating follicle stimulating hormone level2CYP11A1 CL E G H15832590ORPHA:16855846,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiencyHP:0040282 - Frequent31
HP:0030338HP:0011969Elevated circulating luteinizing hormone level2CYP11A1 CL E G H15832590ORPHA:16855846,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiencyHP:0040282 - Frequent31
HP:0030338HP:0011969Elevated circulating luteinizing hormone level2CYP11A1 CL E G H15832590ORPHA:289548Inherited isolated adrenal insufficiency due to partial CYP11A1 deficiencyHP:0040282 - Frequent31
HP:0030338HP:0008232Elevated circulating follicle stimulating hormone level2CYP11A1 CL E G H15832590ORPHA:289548Inherited isolated adrenal insufficiency due to partial CYP11A1 deficiencyHP:0040282 - Frequent31
HP:0030338HP:0011969Elevated circulating luteinizing hormone level2CYP17A1 CL E G H15862593ORPHA:9079646,XY disorder of sex development due to isolated 17,20-lyase deficiencyHP:0040281 - Very frequent53
HP:0030338HP:0008232Elevated circulating follicle stimulating hormone level2CYP17A1 CL E G H15862593ORPHA:9079646,XY disorder of sex development due to isolated 17,20-lyase deficiencyHP:0040281 - Very frequent53
HP:0030338HP:0008232Elevated circulating follicle stimulating hormone level2CYP17A1 CL E G H15862593ORPHA:90793Congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiencyHP:0040282 - Frequent53
HP:0030338HP:0011969Elevated circulating luteinizing hormone level2CYP17A1 CL E G H15862593ORPHA:90793Congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiencyHP:0040282 - Frequent53
HP:0030338HP:0011969Elevated circulating luteinizing hormone level2DHX37 CL E G H5764717210OMIM:27325046, XY sex reversal 112
HP:0030338HP:0008232Elevated circulating follicle stimulating hormone level2DHX37 CL E G H5764717210OMIM:27325046, XY sex reversal 112
HP:0030338HP:0011969Elevated circulating luteinizing hormone level2DHX37 CL E G H5764717210ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent2
HP:0030338HP:0008232Elevated circulating follicle stimulating hormone level2DHX37 CL E G H5764717210ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent2
HP:0030338HP:0008232Elevated circulating follicle stimulating hormone level2DIAPH2 CL E G H17302877OMIM:300511Premature ovarian failure 2A6
HP:0030338HP:0011969Elevated circulating luteinizing hormone level2DIAPH2 CL E G H17302877OMIM:300511Premature ovarian failure 2A6
HP:0030338HP:0008232Elevated circulating follicle stimulating hormone level2DMRT3 CL E G H5852413909ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent1
HP:0030338HP:0011969Elevated circulating luteinizing hormone level2DMRT3 CL E G H5852413909ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent1
HP:0030338HP:0030341Decreased circulating follicle stimulating hormone concentration2DMXL2 CL E G H233122938ORPHA:453533Polyendocrine-polyneuropathy syndromeHP:0040282 - Frequent3
HP:0030338HP:0030344Decreased circulating luteinizing hormone level2DMXL2 CL E G H233122938ORPHA:453533Polyendocrine-polyneuropathy syndromeHP:0040282 - Frequent3
HP:0030338HP:0008232Elevated circulating follicle stimulating hormone level2ERCC6 CL E G H20743438OMIM:616946PREMATURE OVARIAN FAILURE 11; POF11199
HP:0030338HP:0011969Elevated circulating luteinizing hormone level2ESR2 CL E G H21003468OMIM:618187Ovarian dysgenesis 8.
HP:0030338HP:0008232Elevated circulating follicle stimulating hormone level2ESR2 CL E G H21003468OMIM:618187Ovarian dysgenesis 8.
HP:0030338HP:0008232Elevated circulating follicle stimulating hormone level2FANCM CL E G H5769723168OMIM:618086Spermatogenic failure 28.107
HP:0030338HP:0011969Elevated circulating luteinizing hormone level2FANCM CL E G H5769723168OMIM:618086Spermatogenic failure 28.107
HP:0030338HP:0011969Elevated circulating luteinizing hormone level2FGD1 CL E G H22453663OMIM:305400Aarskog-Scott syndrome62
HP:0030338HP:0008232Elevated circulating follicle stimulating hormone level2FGD1 CL E G H22453663OMIM:305400Aarskog-Scott syndrome62
HP:0030338HP:0011969Elevated circulating luteinizing hormone level2FIGLA CL E G H34401824669OMIM:612310PREMATURE OVARIAN FAILURE 6; POF617
HP:0030338HP:0008232Elevated circulating follicle stimulating hormone level2FIGLA CL E G H34401824669OMIM:612310PREMATURE OVARIAN FAILURE 6; POF617
HP:0030338HP:0008232Elevated circulating follicle stimulating hormone level2FKBP6 CL E G H84683722OMIM:620103
HP:0030338HP:0011969Elevated circulating luteinizing hormone level2FOXL2 CL E G H6681092ORPHA:572333Blepharophimosis-ptosis-epicanthus inversus syndrome plusHP:0040283 - Occasional92
HP:0030338HP:0008232Elevated circulating follicle stimulating hormone level2FOXL2 CL E G H6681092ORPHA:572333Blepharophimosis-ptosis-epicanthus inversus syndrome plusHP:0040283 - Occasional92
HP:0030338HP:0030341Decreased circulating follicle stimulating hormone concentration2FSHB CL E G H24883964OMIM:229070Hypogonadotropic hypogonadism 24 without anosmia23
HP:0030338HP:0011969Elevated circulating luteinizing hormone level2FSHB CL E G H24883964OMIM:229070Hypogonadotropic hypogonadism 24 without anosmia23
HP:0030338HP:0008232Elevated circulating follicle stimulating hormone level2GATA4 CL E G H26264173ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent87
HP:0030338HP:0011969Elevated circulating luteinizing hormone level2GATA4 CL E G H26264173ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent87
HP:0030338HP:0011969Elevated circulating luteinizing hormone level2GCNA CL E G H9395315805OMIM:301077SPERMATOGENIC FAILURE, X-LINKED, 4; SPGFX4
HP:0030338HP:0008232Elevated circulating follicle stimulating hormone level2GCNA CL E G H9395315805OMIM:301077SPERMATOGENIC FAILURE, X-LINKED, 4; SPGFX4
HP:0030338HP:0008232Elevated circulating follicle stimulating hormone level2GDF9 CL E G H26614224OMIM:618014Premature ovarian failure 14.2
HP:0030338HP:0011969Elevated circulating luteinizing hormone level2GDF9 CL E G H26614224OMIM:618014Premature ovarian failure 14.2
HP:0030338HP:0030344Decreased circulating luteinizing hormone level2HESX1 CL E G H88204877ORPHA:226307Hypothyroidism due to deficient transcription factors involved in pituitary development or functionHP:0040283 - Occasional21
HP:0030338HP:0030341Decreased circulating follicle stimulating hormone concentration2HESX1 CL E G H88204877ORPHA:226307Hypothyroidism due to deficient transcription factors involved in pituitary development or functionHP:0040283 - Occasional21
HP:0030338HP:0030344Decreased circulating luteinizing hormone level2KISS1 CL E G H38146341OMIM:614842Hypogonadotropic hypogonadism 13 with or without anosmia3
HP:0030338HP:0030341Decreased circulating follicle stimulating hormone concentration2KISS1 CL E G H38146341OMIM:614842Hypogonadotropic hypogonadism 13 with or without anosmia3
HP:0030338HP:0011969Elevated circulating luteinizing hormone level2KISS1R CL E G H846344510OMIM:176400Precocious puberty, central.14
HP:0030338HP:0008232Elevated circulating follicle stimulating hormone level2KISS1R CL E G H846344510OMIM:176400Precocious puberty, central.14
HP:0030338HP:0030341Decreased circulating follicle stimulating hormone concentration2LGR4 CL E G H5536613299OMIM:619613DELAYED PUBERTY, SELF-LIMITED; DPSL1
HP:0030338HP:0030344Decreased circulating luteinizing hormone level2LGR4 CL E G H5536613299OMIM:619613DELAYED PUBERTY, SELF-LIMITED; DPSL1
HP:0030338HP:0030344Decreased circulating luteinizing hormone level2LHB CL E G H39726584OMIM:228300Hypogonadotropic hypogonadism 23 without anosmia.9
HP:0030338HP:0008232Elevated circulating follicle stimulating hormone level2LHB CL E G H39726584OMIM:228300Hypogonadotropic hypogonadism 23 without anosmia9
HP:0030338HP:0030341Decreased circulating follicle stimulating hormone concentration2LHX3 CL E G H80226595ORPHA:226307Hypothyroidism due to deficient transcription factors involved in pituitary development or functionHP:0040283 - Occasional51
HP:0030338HP:0030344Decreased circulating luteinizing hormone level2LHX3 CL E G H80226595ORPHA:226307Hypothyroidism due to deficient transcription factors involved in pituitary development or functionHP:0040283 - Occasional51
HP:0030338HP:0030344Decreased circulating luteinizing hormone level2LHX4 CL E G H8988421734ORPHA:226307Hypothyroidism due to deficient transcription factors involved in pituitary development or functionHP:0040283 - Occasional43
HP:0030338HP:0030341Decreased circulating follicle stimulating hormone concentration2LHX4 CL E G H8988421734ORPHA:226307Hypothyroidism due to deficient transcription factors involved in pituitary development or functionHP:0040283 - Occasional43
HP:0030338HP:0011969Elevated circulating luteinizing hormone level2MAP3K1 CL E G H42146848ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent13
HP:0030338HP:0008232Elevated circulating follicle stimulating hormone level2MAP3K1 CL E G H42146848ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent13
HP:0030338HP:0008232Elevated circulating follicle stimulating hormone level2MCM8 CL E G H8451516147OMIM:612885Premature ovarian failure 104
HP:0030338HP:0011969Elevated circulating luteinizing hormone level2MCM8 CL E G H8451516147OMIM:612885Premature ovarian failure 10.4
HP:0030338HP:0008232Elevated circulating follicle stimulating hormone level2MCM9 CL E G H25439421484OMIM:616185Ovarian dysgenesis 44
HP:0030338HP:0008232Elevated circulating follicle stimulating hormone level2MSH4 CL E G H44387327OMIM:619938
HP:0030338HP:0011969Elevated circulating luteinizing hormone level2MSH4 CL E G H44387327OMIM:619938
HP:0030338HP:0008232Elevated circulating follicle stimulating hormone level2MSH5 CL E G H44397328OMIM:617442Premature ovarian failure 135
HP:0030338HP:0030341Decreased circulating follicle stimulating hormone concentration2NF2 CL E G H47717773ORPHA:2495MeningiomaHP:0040282 - Frequent220
HP:0030338HP:0030344Decreased circulating luteinizing hormone level2NF2 CL E G H47717773ORPHA:2495MeningiomaHP:0040282 - Frequent220
HP:0030338HP:0030341Decreased circulating follicle stimulating hormone concentration2NHLH2 CL E G H48087818OMIM:619755HYPOGONADOTROPIC HYPOGONADISM 27 WITHOUT ANOSMIA; HH27
HP:0030338HP:0030344Decreased circulating luteinizing hormone level2NHLH2 CL E G H48087818OMIM:619755HYPOGONADOTROPIC HYPOGONADISM 27 WITHOUT ANOSMIA; HH27
HP:0030338HP:0008232Elevated circulating follicle stimulating hormone level2NR0B1 CL E G H1907960ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent48
HP:0030338HP:0011969Elevated circulating luteinizing hormone level2NR0B1 CL E G H1907960ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent48
HP:0030338HP:0011969Elevated circulating luteinizing hormone level2NR5A1 CL E G H25167983ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent38
HP:0030338HP:0008232Elevated circulating follicle stimulating hormone level2NR5A1 CL E G H25167983ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent38
HP:0030338HP:0008232Elevated circulating follicle stimulating hormone level2NR5A1 CL E G H25167983OMIM:61296546XY sex reversal 338
HP:0030338HP:0011969Elevated circulating luteinizing hormone level2NR5A1 CL E G H25167983OMIM:61296546XY sex reversal 338
HP:0030338HP:0011969Elevated circulating luteinizing hormone level2NR5A1 CL E G H25167983OMIM:612964PREMATURE OVARIAN FAILURE 7; POF738
HP:0030338HP:0008232Elevated circulating follicle stimulating hormone level2NR5A1 CL E G H25167983OMIM:612964PREMATURE OVARIAN FAILURE 7; POF738
HP:0030338HP:0008232Elevated circulating follicle stimulating hormone level2NSMCE2 CL E G H28605326513OMIM:617253Seckel syndrome 10.2
HP:0030338HP:0011969Elevated circulating luteinizing hormone level2NSMCE2 CL E G H28605326513OMIM:617253Seckel syndrome 10.2
HP:0030338HP:0030341Decreased circulating follicle stimulating hormone concentration2OTX2 CL E G H50158522OMIM:613986Pituitary hormone deficiency, combined, 641
HP:0030338HP:0030344Decreased circulating luteinizing hormone level2OTX2 CL E G H50158522OMIM:613986Pituitary hormone deficiency, combined, 641
HP:0030338HP:0030341Decreased circulating follicle stimulating hormone concentration2PDGFB CL E G H51558800ORPHA:2495MeningiomaHP:0040282 - Frequent9
HP:0030338HP:0030344Decreased circulating luteinizing hormone level2PDGFB CL E G H51558800ORPHA:2495MeningiomaHP:0040282 - Frequent9
HP:0030338HP:0030341Decreased circulating follicle stimulating hormone concentration2PIK3CA CL E G H52908975ORPHA:2495MeningiomaHP:0040282 - Frequent162
HP:0030338HP:0030344Decreased circulating luteinizing hormone level2PIK3CA CL E G H52908975ORPHA:2495MeningiomaHP:0040282 - Frequent162
HP:0030338HP:0011969Elevated circulating luteinizing hormone level2POR CL E G H54479208ORPHA:95699Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiencyHP:0040283 - Occasional76
HP:0030338HP:0008232Elevated circulating follicle stimulating hormone level2POR CL E G H54479208ORPHA:95699Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiencyHP:0040283 - Occasional76
HP:0030338HP:0030344Decreased circulating luteinizing hormone level2POU1F1 CL E G H54499210ORPHA:226307Hypothyroidism due to deficient transcription factors involved in pituitary development or functionHP:0040283 - Occasional36
HP:0030338HP:0030341Decreased circulating follicle stimulating hormone concentration2POU1F1 CL E G H54499210ORPHA:226307Hypothyroidism due to deficient transcription factors involved in pituitary development or functionHP:0040283 - Occasional36
HP:0030338HP:0008232Elevated circulating follicle stimulating hormone level2PPP2R3C CL E G H5501217485OMIM:618419Gonadal dysgenesis, dysmorphic facies, retinal dystrophy, and myopathy.
HP:0030338HP:0011969Elevated circulating luteinizing hormone level2PPP2R3C CL E G H5501217485OMIM:618419Gonadal dysgenesis, dysmorphic facies, retinal dystrophy, and myopathy.
HP:0030338HP:0030344Decreased circulating luteinizing hormone level2PRDM13 CL E G H5933613998OMIM:619761CEREBELLAR DYSFUNCTION, IMPAIRED INTELLECTUAL DEVELOPMENT, AND HYPOGONADOTROPIC HYPOGONADISM; CDIDHH2
HP:0030338HP:0030341Decreased circulating follicle stimulating hormone concentration2PRDM13 CL E G H5933613998OMIM:619761CEREBELLAR DYSFUNCTION, IMPAIRED INTELLECTUAL DEVELOPMENT, AND HYPOGONADOTROPIC HYPOGONADISM; CDIDHH2
HP:0030338HP:0030341Decreased circulating follicle stimulating hormone concentration2PROP1 CL E G H56269455ORPHA:226307Hypothyroidism due to deficient transcription factors involved in pituitary development or functionHP:0040283 - Occasional54
HP:0030338HP:0030344Decreased circulating luteinizing hormone level2PROP1 CL E G H56269455ORPHA:226307Hypothyroidism due to deficient transcription factors involved in pituitary development or functionHP:0040283 - Occasional54
HP:0030338HP:0008232Elevated circulating follicle stimulating hormone level2PSMC3IP CL E G H2989317928OMIM:614324Ovarian dysgenesis 32
HP:0030338HP:0011969Elevated circulating luteinizing hormone level2PSMC3IP CL E G H2989317928OMIM:614324Ovarian dysgenesis 32
HP:0030338HP:0030344Decreased circulating luteinizing hormone level2SEMA3A CL E G H1037110723OMIM:614897Hypogonadotropic hypogonadism 16 with or without anosmia14
HP:0030338HP:0030341Decreased circulating follicle stimulating hormone concentration2SEMA3A CL E G H1037110723OMIM:614897Hypogonadotropic hypogonadism 16 with or without anosmia14
HP:0030338HP:0008232Elevated circulating follicle stimulating hormone level2SHOC1 CL E G H15840126535OMIM:619949
HP:0030338HP:0030344Decreased circulating luteinizing hormone level2SMARCB1 CL E G H659811103ORPHA:2495MeningiomaHP:0040282 - Frequent87
HP:0030338HP:0030341Decreased circulating follicle stimulating hormone concentration2SMARCB1 CL E G H659811103ORPHA:2495MeningiomaHP:0040282 - Frequent87
HP:0030338HP:0030344Decreased circulating luteinizing hormone level2SMARCE1 CL E G H660511109ORPHA:2495MeningiomaHP:0040282 - Frequent47
HP:0030338HP:0030341Decreased circulating follicle stimulating hormone concentration2SMARCE1 CL E G H660511109ORPHA:2495MeningiomaHP:0040282 - Frequent47
HP:0030338HP:0030341Decreased circulating follicle stimulating hormone concentration2SMO CL E G H660811119ORPHA:2495MeningiomaHP:0040282 - Frequent22
HP:0030338HP:0030344Decreased circulating luteinizing hormone level2SMO CL E G H660811119ORPHA:2495MeningiomaHP:0040282 - Frequent22
HP:0030338HP:0011969Elevated circulating luteinizing hormone level2SOX9 CL E G H666211204ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent109
HP:0030338HP:0008232Elevated circulating follicle stimulating hormone level2SOX9 CL E G H666211204ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent109
HP:0030338HP:0008232Elevated circulating follicle stimulating hormone level2SPIDR CL E G H2351428971OMIM:619665OVARIAN DYSGENESIS 9; ODG92
HP:0030338HP:0011969Elevated circulating luteinizing hormone level2SPIDR CL E G H2351428971OMIM:619665OVARIAN DYSGENESIS 9; ODG92
HP:0030338HP:0008232Elevated circulating follicle stimulating hormone level2SRY CL E G H673611311ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent23
HP:0030338HP:0011969Elevated circulating luteinizing hormone level2SRY CL E G H673611311ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent23
HP:0030338HP:0008232Elevated circulating follicle stimulating hormone level2SRY CL E G H673611311OMIM:40004546XX sex reversal 1.23
HP:0030338HP:0011969Elevated circulating luteinizing hormone level2SRY CL E G H673611311OMIM:40004546XX sex reversal 1.23
HP:0030338HP:0011969Elevated circulating luteinizing hormone level2SRY CL E G H673611311OMIM:40004446XY sex reversal 1.23
HP:0030338HP:0008232Elevated circulating follicle stimulating hormone level2SRY CL E G H673611311OMIM:40004446XY sex reversal 1.23
HP:0030338HP:0008232Elevated circulating follicle stimulating hormone level2STAG3 CL E G H1073411356OMIM:615723Premature ovarian failure 84
HP:0030338HP:0011969Elevated circulating luteinizing hormone level2STAG3 CL E G H1073411356OMIM:615723Premature ovarian failure 84
HP:0030338HP:0030341Decreased circulating follicle stimulating hormone concentration2SUFU CL E G H5168416466ORPHA:2495MeningiomaHP:0040282 - Frequent124
HP:0030338HP:0030344Decreased circulating luteinizing hormone level2SUFU CL E G H5168416466ORPHA:2495MeningiomaHP:0040282 - Frequent124
HP:0030338HP:0030344Decreased circulating luteinizing hormone level2TERT CL E G H701511730ORPHA:2495MeningiomaHP:0040282 - Frequent238
HP:0030338HP:0030341Decreased circulating follicle stimulating hormone concentration2TERT CL E G H701511730ORPHA:2495MeningiomaHP:0040282 - Frequent238
HP:0030338HP:0030341Decreased circulating follicle stimulating hormone concentration2TRAF7 CL E G H8423120456ORPHA:2495MeningiomaHP:0040282 - Frequent
HP:0030338HP:0030344Decreased circulating luteinizing hormone level2TRAF7 CL E G H8423120456ORPHA:2495MeningiomaHP:0040282 - Frequent
HP:0030338HP:0011969Elevated circulating luteinizing hormone level2VAMP7 CL E G H684511486ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent2
HP:0030338HP:0008232Elevated circulating follicle stimulating hormone level2VAMP7 CL E G H684511486ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent2
HP:0030338HP:0008232Elevated circulating follicle stimulating hormone level2WT1 CL E G H749012796ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent177
HP:0030338HP:0011969Elevated circulating luteinizing hormone level2WT1 CL E G H749012796ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent177
HP:0030338HP:0011969Elevated circulating luteinizing hormone level2WWOX CL E G H5174112799ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent149
HP:0030338HP:0008232Elevated circulating follicle stimulating hormone level2WWOX CL E G H5174112799ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent149
HP:0030338HP:0008232Elevated circulating follicle stimulating hormone level2XRCC2 CL E G H751612829OMIM:619146PREMATURE OVARIAN FAILURE 17; POF17125
HP:0030338HP:0011969Elevated circulating luteinizing hormone level2XRCC2 CL E G H751612829OMIM:619146PREMATURE OVARIAN FAILURE 17; POF17125
HP:0030338HP:0008232Elevated circulating follicle stimulating hormone level2ZFPM2 CL E G H2341416700ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent31
HP:0030338HP:0011969Elevated circulating luteinizing hormone level2ZFPM2 CL E G H2341416700ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent31
HP:0030338HP:0008232Elevated circulating follicle stimulating hormone level2ZMYND15 CL E G H8422520997OMIM:615842Spermatogenic failure 141
HP:0030338HP:0008232Elevated circulating follicle stimulating hormone level2ZSWIM7 CL E G H12515026993OMIM:619834OVARIAN DYSGENESIS 10; ODG10
HP:0030338HP:0011969Elevated circulating luteinizing hormone level2ZSWIM7 CL E G H12515026993OMIM:619834OVARIAN DYSGENESIS 10; ODG10


Genes (108) :AKT1 ANOS1 AR BAP1 BMP15 BMPR1B BNC1 C14ORF39 CBX2 CCDC34 CDH23 CFTR CNBP CPE CYB5A CYP11A1 CYP17A1 DHH DHX37 DIAPH2 DMRT3 DMXL2 ERCC6 ESR1 ESR2 FAM111A FANCM FGD1 FIGLA FKBP6 FMR1 FOXL2 FSHB FSHR GATA4 GCNA GDF9 GNRH1 HESX1 HFM1 HSD17B4 KISS1 KISS1R KLHL10 LARS2 LGR4 LHB LHCGR LHX3 LHX4 MAGEL2 MAP3K1 MCM8 MCM9 MEIOB MRPS22 MSH4 MSH5 NANOS1 NDN NF2 NHLH2 NR0B1 NR5A1 NSMCE2 NUP107 OCA2 OTX2 PDGFB PIK3CA PNLDC1 PNPLA6 POLA1 POLR3H POR POU1F1 PPP2R3C PRDM13 PROP1 PSMC3IP SEMA3A SHOC1 SMARCB1 SMARCE1 SMO SNRPN SOHLH1 SOX9 SPIDR SRY STAG3 SUFU SYCE1 SYCP3 TAF4B TDRD9 TERT TEX11 TEX14 TEX15 TRAF7 VAMP7 WT1 WWOX XRCC2 ZFPM2 ZMYND15 ZSWIM7

Diseases (79) :ORPHA:2495 OMIM:308700 OMIM:300068 ORPHA:99429 ORPHA:90797 ORPHA:243 OMIM:609441 OMIM:618723 ORPHA:399805 OMIM:619203 OMIM:613080 ORPHA:91347 OMIM:602668 OMIM:619326 ORPHA:90796 ORPHA:168558 ORPHA:289548 ORPHA:90793 ORPHA:168563 OMIM:273250 ORPHA:251510 OMIM:300511 ORPHA:453533 OMIM:616946 ORPHA:785 OMIM:618187 ORPHA:93325 OMIM:618086 OMIM:305400 OMIM:612310 OMIM:620103 OMIM:311360 OMIM:110100 ORPHA:572333 OMIM:229070 OMIM:233300 ORPHA:64739 OMIM:301077 OMIM:618014 OMIM:614841 ORPHA:226307 OMIM:615724 OMIM:233400 OMIM:614842 OMIM:176400 OMIM:615300 OMIM:619613 OMIM:228300 OMIM:238320 ORPHA:98754 ORPHA:177901 ORPHA:177904 OMIM:612885 OMIM:616185 OMIM:619938 OMIM:617442 ORPHA:399808 OMIM:619755 OMIM:612965 OMIM:612964 OMIM:617253 OMIM:613986 OMIM:215470 ORPHA:163976 ORPHA:95699 OMIM:618419 OMIM:619761 OMIM:614324 OMIM:614897 OMIM:619949 OMIM:619665 ORPHA:1772 OMIM:400045 OMIM:400044 OMIM:615723 ORPHA:347 OMIM:619146 OMIM:615842 OMIM:619834
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.